News
TWST
30.75
-2.38%
-0.75
Weekly Report: what happened at TWST last week (0415-0419)?
Weekly Report · 2d ago
Press Release: Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024 Company to host conference call at 4:30 p.m. ET for analysts and investors. The company will issue its financial results for the fiscal 2024 second quarter ended March 31, 2024. Twist is a leading synthetic biology and genomics company.
Dow Jones · 6d ago
Twist Bioscience Becomes Oversold (TWST)
NASDAQ · 04/15 20:55
Weekly Report: what happened at TWST last week (0408-0412)?
Weekly Report · 04/15 09:04
Twist Bioscience: Statement of changes in beneficial ownership of securities
Press release · 04/11 22:25
Analyst Scoreboard: 5 Ratings For Twist Bioscience
Twist Bioscience Corp is a synthetic biology company. The company develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The average price target is $43.6, with a 12-month target of $45.00. 5 analysts have released ratings for Twist BiosScience in the last three months.
Benzinga · 04/10 20:00
Twist Bioscience Is Maintained at Overweight by Barclays
Dow Jones · 04/10 19:36
Twist Bioscience Price Target Cut to $40.00/Share From $45.00 by Barclays
Dow Jones · 04/10 19:36
Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $40
Benzinga · 04/10 19:25
Barclays Sticks to Their Buy Rating for Twist Bioscience (TWST)
TipRanks · 04/10 06:47
Weekly Report: what happened at TWST last week (0401-0405)?
Weekly Report · 04/08 09:04
Recent 3.3% pullback isn't enough to hurt long-term Twist Bioscience (NASDAQ:TWST) shareholders, they're still up 149% over 1 year
Twist Bioscience Corporation (NASDAQ:TWST) saw its share price drop 13% in the last month. The company's share price shot up 149% over the last year. In the last 12 months, the company saw its revenue grow by 22%. The company didn't make a profit in the same period. We look at the growth of the company's earnings and revenue to see if the business is trending in the right direction.
Simply Wall St · 04/04 11:47
Twist Bioscience: Report of proposed sale of securities
Press release · 04/02 20:49
Weekly Report: what happened at TWST last week (0325-0329)?
Weekly Report · 04/01 09:04
Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip
Cathie Wood-led Ark Invest purchased a substantial number of shares in Tesla Inc. On Thursday. The value of the Tesla shares bought by Ark Invest on Thursday is estimated to be around $14 million. This comes after the electric vehicle giant's stock price tumbled nearly 2.25%.
Benzinga · 03/29 02:09
Weekly Report: what happened at TWST last week (0318-0322)?
Weekly Report · 03/25 09:04
Twist Bioscience: Statement of changes in beneficial ownership of securities
Press release · 03/22 20:18
Buy Rating Justified: Twist Bioscience’s Strong Demand and Strategic Expansion Signal Market Share Growth
TipRanks · 03/21 06:37
Weekly Report: what happened at TWST last week (0311-0315)?
Weekly Report · 03/18 09:04
Noteworthy ETF Outflows: ARKG, CRSP, TWST, RXRX
NASDAQ · 03/14 15:06
More
Webull provides a variety of real-time TWST stock news. You can receive the latest news about Twist Bioscience through multiple platforms. This information may help you make smarter investment decisions.
About TWST
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. It has miniaturized traditional chemical DNA synthesis reactions to write over one million short pieces of DNA on each silicon chip. It offers two product lines: synthetic biology tools and NGS tools, that address different needs of its customers across a variety of applications. It offers ribonucleic acid and protein products. Its synthetic biology products include synthetic genes and gene fragments, and oligonucleotide or oligo pools.